Core Scientific, Inc.

CORZNASDAQTechnology● Active

$26.98

+$1.13(+4.35%)

Market Cap$8.6B

P/E Ratio—

52W High$30.46

52W Low$10.93

Avg Volume14.0M

Open$26.66

Beta5.48

Free Cash Flow Financials Revenue

Core Scientific, Inc. (CORZ) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

CORZ · free cash flow · updated Jun 8, 2026

Core FCF metrics

CORZ · FCF · TTM · margin & CAGR

Free cash flow was −$450.8M for FY2025 (fiscal year ending 2025-12-31), down 765.7% year-over-year The FCF margin was -141.3%.

FY2025 Free Cash Flow−$450.8M▼ -765.7% YoY

Trailing 12M (TTM)−$471.2Mtrailing 4 quarters sum

FCF Margin-141.3%−$450.8M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

CORZ · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$278.3M(729M)−$450.8M▼ 765.7%-141.3%

FY2024$42.9M(95M)−$52.1M▼ 206.4%-10.2%

FY2023$65.1M(16M)$49.0M▲ +112.3%9.7%

FY2022$205.2M(602M)−$396.5M▼ 241.8%-61.9%

FY2021−$56.7M(59M)−$116.0M▼ 357.9%-21.3%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

CORZ · P/FCF · FCF yield · FCF per share

Core Scientific, Inc. (CORZ) reported negative free cash flow of −$0.45B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

CORZ · cash flow statement · operating / investing / financing

For FY2025, Core Scientific, Inc. generated $278.3M in operating cash flow and spent 729M in capital expenditures, yielding −$450.8M in free cash flow.

Operating Activities

+$278.3M

Cash from core business operations

2025-12-31

Investing Activities

−$740.8M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

−$63.1M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF ($278.3M) − |CapEx| (729M) = FCF (−$450.8M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Technology)

CORZ vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Core Scientific, Inc.YOU

CORZ

−$450.8M-765.7%-141.3%

Loss

Taiwan Semiconductor Manufacturing Company Limited

Microsoft Corporation

Technology · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Core Scientific, Inc. (CORZ) reported free cash flow of −$450.8M for FY2025 (fiscal year ending 2025-12-31), down 765.7% year-over-year. The FCF margin was -141.3%.

Based on available data, Core Scientific, Inc. has maintained positive free cash flow for at least 1 fiscal year(s). FCF peaked at $49.0M in FY2023.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

CORZ free cash flow · 8 questions

Core Scientific, Inc. free cash flow was −$450.8M for FY2025, down 765.7% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$471.2M.

CORZ free cash flowCORZ FCFCORZ FCF 2025CORZ free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Core Scientific, Inc. · Core Scientific, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026